Literature DB >> 6230259

The influence of androgens on insulin resistance.

D Shoupe, R A Lobo.   

Abstract

Insulin resistance (IR) in polycystic ovary syndrome (PCO) has been linked to hyperandrogenism and elevated luteinizing hormone (LH) levels. Fourteen patients with idiopathic hirsutism (IH), 13 with PCO, and 6 control subjects were investigated for assessment of the effects of serum LH, peripheral tissue androgens, and sex hormone-binding globulin (SHBG) on fasting immunoreactive insulin (IRI) levels. Serum LH, dehydroepiandrosterone sulfate, dihydrotestosterone, and 3 alpha-androstanediol, SHBG, and unbound testosterone (uT) were measured. Serum testosterone (T) showed a positive correlation with IRI (P less than 0.05), and SHBG showed a negative correlation (P less than 0.02). Unbound T showed a highly significant positive correlation (P less than 0.001), whereas dehydroepiandrosterone sulfate, dihydrotestosterone, and 3 alpha-androstanediol did not correlate. Gonadotropin-releasing hormone, administered to patients with IH, raised LH levels but did not change IRI levels. Spironolactone did not affect T or IRI in patients with IH but significantly lowered T and IRI in patients with PCO. It is suggested that IR is not related to LH or peripheral androgen metabolism but highly correlated with uT and SHBG, thus coupling two important factors in IR, obesity and the androgen level.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230259

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Hyperandrogenism, hyperinsulinism and polycystic ovarian disease.

Authors:  R Pasquali; S Venturoli
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

2.  Reduction of insulin resistance after correction of nonneoplastic ovarian virilization.

Authors:  M Baldini; E Semprini; A Orsatti; G Viale; L Cantalamessa
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

3.  Role of lipids in development of noninsulin-dependent diabetes mellitus: lessons learned from Pima Indians.

Authors:  P A Tataranni; L J Baier; G Paolisso; B V Howard; E Ravussin
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Evaluation of insulin sensitivity in patients with Klinefelter's syndrome: a hyperinsulinemic euglycemic clamp study.

Authors:  Zeki Yesilova; Cagatay Oktenli; S Yavuz Sanisoglu; Ugur Musabak; Erdinc Cakir; Metin Ozata; Kemal Dagalp
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

Review 5.  Genetic and environmental aspect of polycystic ovary syndrome.

Authors:  E Carmina
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

6.  Insulin resistance and secretion in polycystic ovarian disease.

Authors:  B Bruno; G Poccia; A Fabbrini
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

7.  Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C.

Authors:  W Urdl
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

8.  A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances.

Authors:  F Ramezani Tehrani; S Behboudi-Gandevani; M Simbar; F Azizi
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

9.  Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo.

Authors:  G Schernthaner; R Prager; C Punzengruber; A Luger
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

10.  Direct relationship between elevated free testosterone and insulin resistance in hyperprolactinemic women.

Authors:  S Y Kim; Y A Sung; K S Ko; B Y Cho; H K Lee; C S Koh; H K Min
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.